Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB
- PMID: 35996292
- DOI: 10.5588/ijtld.22.0328
Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB
Comment in
-
Tailored TB preventive treatment for drug-resistant TB - failing the test for appropriateness?Int J Tuberc Lung Dis. 2022 Dec 1;26(12):1198. doi: 10.5588/ijtld.22.0522. Int J Tuberc Lung Dis. 2022. PMID: 36447329 No abstract available.
-
Tailored TPT for drug-resistant TB - promoting equity and access to optimal care.Int J Tuberc Lung Dis. 2023 Jan 1;27(1):89b-90. doi: 10.5588/ijtld.22.0538. Int J Tuberc Lung Dis. 2023. PMID: 36853142 No abstract available.
Comment on
-
WHO target product profiles for TB preventive treatment.Int J Tuberc Lung Dis. 2022 Apr 1;26(4):302-309. doi: 10.5588/ijtld.21.0667. Int J Tuberc Lung Dis. 2022. PMID: 35351234 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources